Although, NFKB2, RELB and IKBKG/NEMO were increased in all MASLD cases, the correlation between FGF21 and IKBKG/NEMO was strictly negative (Figure S9B). This evidence concerns the gene NFKB2 and metabolic dysfunction-associated steatotic liver disease.